Zagorec, N, Calamel, A, Ars, E, Ong, A, Halbritter, J, Audrezet, MP, Pillay, VG, Meur, YL, Sayer, J, Cornec-Le Gall, E. Clinical spectrum and prognosis of the atypical polycystic kidney disease caused by monoallelic loss-of-function IFT140 variants. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.119. PMID:. IF:5.600(Q1/1D).

Gosselink, ME, Snoek, R, Cerkauskaite-Kerpauskiene, A, van Bakel, SPJ, Vollenberg, R, Groen, H, Cerkauskiene, R, Miglinas, M, Attini, R, Tory, K, Claes, KJ, van Calsteren, K, Servais, A, de Jong, MFC, Gillion, V, Vogt, L, Mastrangelo, A, Furlano, M, Torra, R, Bramham, K, Wiles, K, Ralston, ER, Hall, M, Liu, LS, Hladunewich, MA, Lely, AT, van Eerde, AM. Reassuring pregnancy outcomes in women with mild COL4A3-5 - related disease (Alport syndrome) and genetic type of disease can aid personalized counseling. KIDNEY INTERNATIONAL. 2024; 105(5)DOI:10.1016/j.kint.2024.01.034. PMID:38382843. IF:12.600(Q1/1D).

Torra, R. Kidney health matters: a global imperative for public health. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39(9)DOI:10.1093/ndt/gfae083. PMID:38578651. IF:5.600(Q1/1D).

Bover J., Gómez-Alonso C., Casado E., Rodríguez-García M., Lloret M.J., Castro-Alonso C., Gifre L., Henríquez-Palop F., Prior-Español Á., López de la Manzanara V., Láiz A.M., Martínez-Ferrer À., Torregrosa J.V., Cigarrán S., Górriz J.L., Montomoli M., Panizo N., Costa E., Martínez-Laguna D., Rodríguez M., Navarro-González J.F.. Manejo de la osteoporosis en el paciente con enfermedad renal crónica (Estudio ERCOS): un desafío en la asistencia nefrológica. NEFROLOGIA. 2024; 44(2)DOI:10.1016/j.nefro.2023.05.002. PMID:38531765. IF:2.600(Q2/4D).

Lloret, MJ, Jorgensen, HS, Evenepoel, P. Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?. Clinical Kidney Journal. 2024; 17(3)DOI:10.1093/ckj/sfae048. PMID:38500493. IF:4.600(Q1/2D).

Bover, J, Gómez-Alonso, C, Casado, E, Rodríguez-García, M, Lloret, MJ, Castro-Alonso, C, Gifre, L, Henríquez-Palop, F, Prior-Español, A, de la Manzanara, VL, Láiz, AM, Martínez-Ferrer, A, Torregrosa, JV, Cigarrán, S, Górriz, JL, Montomoli, M, Panizo, N, Costa, E, Martínez-Laguna, D, Rodríguez, M, Navarro-González, JF. Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care. NEFROLOGIA. 2024; 44(2)DOI:10.1016/j.nefroe.2024.03.005. PMID:. IF:2.600(Q2/4D).

Bais, T, Meijer, E, Kramers, BJ, Vart, P, Vervloet, M, Salih, M, Bammens, B, Demoulin, N, Todorova, P, Müller, RU, Halbritter, J, Paliege, A, Gall, ECL, Knebelmann, B, Torra, R, Ong, ACM, Frankl, FEK, Gansevoort, RT. HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial. Trials. 2024; 25(1)DOI:10.1186/s13063-024-07952-x. PMID:38355627. IF:2.000(Q3/7D).

Lloret, MJ, Fusaro, M, Jorgensen, HS, Haarhaus, M, Gifre, L, Alfieri, CM, Masso, E, D'Marco, L, Evenepoel, P, Bover, J. Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter. Journal of Clinical Medicine. 2024; 13(4)DOI:10.3390/jcm13041010. PMID:38398323. IF:2.900(Q1/2D).